Defining and characterizing the progression of type 2 diabetes
This dual action makes tirzepatide more effective at preferentially targeting fat tissue and preserving muscle
In perimenopausal or postmenopausal women, early data support efficacy regardless of reproductive stage , although research focused specifically on perimenopause remains limited
Many people experience steady weight loss for the first two years, then stall or regain some weight after that
Secondary metabolic markers include fasting glucose, insulin sensitivity via HOMA-IR or glucose tolerance testing, body composition changes (DEXA scan or MRI for fat mass and lean mass distribution), mitochondrial respiration capacity via Seahorse analyzer, and serum markers like HbA1c for long-term glucose control
Nutr Cancer (2023) 75(1):1423